Skip to main content
Premium Trial:

Request an Annual Quote

Sloning Biotechnology Closes 4.3M Series B

NEW YORK, April 10 - German genomics-tool start up Sloning Biotechnology Sloning BioTechnology today said it has closed 4.3 million, or $4.6 million, in a Series B round of private-equity financing.


The company said it will use the cash to complete the automation of its eponymous gene-synthesis technology, and to prepare for market entry.


HBM Partners led the round, which included investments by DEWB and 3i.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.